NEXT vs NEUP: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

NEUP has stronger fundamentals based on our AI analysis.

NEXT
NextDecade Corp
STRONG SELL
88%
Confidence
VS
NEUP
Neuphoria Therapeutics Inc.
SELL
68%
Confidence

NEXT vs NEUP Fundamental Comparison

Metric NEXT NEUP
Revenue $0.0 $15.6M
Net Income $-429.6M $-8.0M
Net Margin N/A -51.4%
ROE -450.6% -27.1%
ROA -3.5% -22.0%
Current Ratio 0.54x 9.04x
Debt/Equity 92.59x 0.00x
EPS $-1.17 $-2.66

Green = Better metric | Red = Weaker metric

View Full NEXT Analysis →
View Full NEUP Analysis →

You Might Also Compare

NEXT vs AAPL NEUP vs MSFT NEXT vs GOOGL NEUP vs AMZN

NEXT vs NEUP: Frequently Asked Questions

Is NEXT or NEUP a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), NEUP has stronger fundamentals. NEXT is rated STRONG SELL (88% confidence) while NEUP is rated SELL (68% confidence). This is not investment advice.

How does NEXT compare to NEUP fundamentally?

NextDecade Corp has ROE of -450.6% vs Neuphoria Therapeutics Inc.'s -27.1%. Net margins are N/A vs -51.4% respectively.

Which stock pays higher dividends, NEXT or NEUP?

NEXT has a dividend yield of N/A or no dividend while NEUP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in NEXT or NEUP for long term?

For long-term investing, consider that NEXT has STRONG SELL rating with 88% confidence, while NEUP has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about NEXT vs NEUP?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NEXT vs NEUP, the AI consensus favors NEUP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.